Brief: Pharmaust Says Michael Thurn Appointed As CEO Effective 1 September
28/08/2023 04:15
Aug 28 (Reuters) - Pharmaust PAA.AX :
* MICHAEL THURN APPOINTED AS CEO EFFECTIVE 1 SEPTEMBER
* ROGER ASTON WILL REMAIN CHAIRMAN OF BOARD BUT WILL
TRANSITION
INTO NON-EXECUTIVE ROLE
Source text for Eikon: ID:nASX2m0CCw
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO